These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1704621)

  • 1. Effects of risperidone on motor and sexual activity in the rat.
    Genazzani A; Mauceri F; Valerio C; Nardo L; Drago F
    Pharmacol Res; 1990; 22 Suppl 1():61-2. PubMed ID: 1704621
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol.
    Megens AA; Awouters FH; Niemegeers CJ
    Psychopharmacology (Berl); 1988; 95(4):493-6. PubMed ID: 2463650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
    Megens AA; Niemegeers CJ; Awouters FH
    J Pharmacol Exp Ther; 1992 Jan; 260(1):160-7. PubMed ID: 1370539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Janssen PA
    Neuropharmacology; 1989 Dec; 28(12):1431-3. PubMed ID: 2482460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antipsychotic agent, risperidone, introduced.
    Am J Hosp Pharm; 1994 May; 51(9):1145. PubMed ID: 7518997
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
    Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
    Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdose of risperidone.
    Brown K; Levy H; Brenner C; Leffler S; Hamburg EL
    Ann Emerg Med; 1993 Dec; 22(12):1908-10. PubMed ID: 7694530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats.
    Drago F; Contarino A; Marino R; Anzallo C; Valerio C; Rampello L; Raffaele R; Scapagnini U
    Pharmacol Res; 1997 Jan; 35(1):17-25. PubMed ID: 9149311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey on the pharmacodynamics of the new antipsychotic risperidone.
    Megens AA; Awouters FH; Schotte A; Meert TF; Dugovic C; Niemegeers CJ; Leysen JE
    Psychopharmacology (Berl); 1994 Feb; 114(1):9-23. PubMed ID: 7531353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone: integrating research and practice.
    Addington D
    Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    Schreiber R; Brocco M; Millan MJ
    Eur J Pharmacol; 1994 Oct; 264(1):99-102. PubMed ID: 7530204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.
    Panocka I; Pompei P; Massi M
    Brain Res Bull; 1993; 31(5):595-9. PubMed ID: 7684315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptics and the immune system.
    Nyulassy S; Jahnová E; Keleová A
    Cesk Psychiatr; 1993 Jan; 89(1):30-4. PubMed ID: 7685246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approved new drug bulletin: risperidone (risperdal).
    RN; 1994 Jun; 57(6):45-6. PubMed ID: 7526438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.